ArticleBMC public health2026
Exploring sexual health challenges in men with type 2 diabetes-related erectile dysfunction: a qualitative study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 2 diabetes mellitus (T2DM) is a prevalent chronic disease that is frequently associated with erectile dysfunction (ED). This complication adversely affects sexual function, quality of life, marital relationships, and psychological well-being. Despite its high prevalence, sexual health issues remain overlooked, especially with respect to diabetes management. This qualitative study explored sexual health challenges from the perspective of Iranian men with T2DM and ED.
methodsUsing conventional content analysis, semistructured interviews were conducted in 2025 with 19 purposively selected men experiencing T2DM-related ED from Shariati Hospital. Data analysis followed the approach of Graneheim and Lundman. Trustworthiness was ensured through member checking and intercoder reliability (Kappa = 0.82).
resultsThe participants’ average age was 49.8 ± 8.2 years. Most were middle-aged (51.8%), married (89.5%), and had been living with diabetes for less than 10 years (78.9%). Educational and occupational backgrounds varied widely. Qualitative analysis identified the main theme of “silent distress,” which included four categories: (1) Shaming and embarrassment in the disclosure ED: Fear of social disgrace and cultural constraints prevented discussion of the ED; (2) Fragmentation of sexual identity: ED reduced sexual self-confidence, caused feelings of humiliation, and damaged masculine identity. (3) Threat to marital life: Participants worried about spousal rejection and potential relationship breakdown. (4) Inadequate sexual healthcare services: Major barriers include a lack of awareness among patients and physicians about the diabetes-ED connection, the absence of sexual counseling during visits, and a lack of private clinical environments.
conclusionED in men with T2DM causes significant psychosocial distress, creating a cycle of “silent distress.” This situation is worsened by cultural barriers (stigma preventing disclosure), educational gaps (insufficient patient/provider awareness), and structural issues (lack of private counseling). Key solutions include integrating sexual counseling into routine diabetes care; training healthcare teams to address sexual health proactively; establishing confidential clinical environments; and launching public awareness campaigns to reduce stigma. These strategies are essential not only for improving quality of life but also for breaking the cycle of silent distress and possibly enhancing adherence to diabetes treatment.
trial registrationNot applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.